vs
Lifeway Foods, Inc.（LWAY）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
Lifeway Foods, Inc.的季度营收约是RECURSION PHARMACEUTICALS, INC.的1.6倍（$55.4M vs $35.5M），Lifeway Foods, Inc.净利率更高（4.6% vs -304.2%，领先308.8%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 18.0%），Lifeway Foods, Inc.自由现金流更多（$-17.4M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 11.4%）
来福威食品公司是一家总部位于美国伊利诺伊州的健康食品企业，成立于1986年，是美国业内领先的开菲尔发酵益生菌产品供应商，这类产品主要用于调节人体微生物群平衡。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
LWAY vs RXRX — 直观对比
营收规模更大
LWAY
是对方的1.6倍
$35.5M
营收增速更快
RXRX
高出663.8%
18.0%
净利率更高
LWAY
高出308.8%
-304.2%
自由现金流更多
LWAY
多$29.9M
$-47.3M
两年增速更快
RXRX
近两年复合增速
11.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $55.4M | $35.5M |
| 净利润 | $2.5M | $-108.1M |
| 毛利率 | 27.8% | 59.8% |
| 营业利润率 | 6.8% | -304.8% |
| 净利率 | 4.6% | -304.2% |
| 营收同比 | 18.0% | 681.7% |
| 净利润同比 | 1688.1% | 39.6% |
| 每股收益（稀释后） | $0.15 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LWAYRXRX
| Q4 25 | $55.4M | $35.5M | ||
| Q3 25 | $57.1M | $5.2M | ||
| Q2 25 | $53.9M | $19.2M | ||
| Q1 25 | $46.1M | $14.7M | ||
| Q4 24 | $46.9M | $4.5M | ||
| Q3 24 | $46.1M | $26.1M | ||
| Q2 24 | $49.2M | $14.4M | ||
| Q1 24 | $44.6M | $13.8M |
净利润LWAYRXRX
| Q4 25 | $2.5M | $-108.1M | ||
| Q3 25 | $3.5M | $-162.3M | ||
| Q2 25 | $4.2M | $-171.9M | ||
| Q1 25 | $3.5M | $-202.5M | ||
| Q4 24 | $-160.0K | $-178.9M | ||
| Q3 24 | $3.0M | $-95.8M | ||
| Q2 24 | $3.8M | $-97.5M | ||
| Q1 24 | $2.4M | $-91.4M |
毛利率LWAYRXRX
| Q4 25 | 27.8% | 59.8% | ||
| Q3 25 | 28.7% | -183.8% | ||
| Q2 25 | 28.6% | -4.9% | ||
| Q1 25 | 23.9% | -48.0% | ||
| Q4 24 | 25.3% | -181.4% | ||
| Q3 24 | 25.7% | 53.7% | ||
| Q2 24 | 27.0% | 36.2% | ||
| Q1 24 | 25.8% | 19.1% |
营业利润率LWAYRXRX
| Q4 25 | 6.8% | -304.8% | ||
| Q3 25 | 8.8% | -3327.6% | ||
| Q2 25 | 10.8% | -916.8% | ||
| Q1 25 | 3.4% | -1297.9% | ||
| Q4 24 | 1.5% | -4042.4% | ||
| Q3 24 | 9.1% | -377.1% | ||
| Q2 24 | 11.0% | -697.4% | ||
| Q1 24 | 8.0% | -698.4% |
净利率LWAYRXRX
| Q4 25 | 4.6% | -304.2% | ||
| Q3 25 | 6.2% | -3135.3% | ||
| Q2 25 | 7.9% | -894.2% | ||
| Q1 25 | 7.7% | -1373.3% | ||
| Q4 24 | -0.3% | -3935.5% | ||
| Q3 24 | 6.5% | -367.5% | ||
| Q2 24 | 7.7% | -676.6% | ||
| Q1 24 | 5.4% | -662.4% |
每股收益（稀释后）LWAYRXRX
| Q4 25 | $0.15 | $-0.17 | ||
| Q3 25 | $0.23 | $-0.36 | ||
| Q2 25 | $0.28 | $-0.41 | ||
| Q1 25 | $0.23 | $-0.50 | ||
| Q4 24 | $0.00 | $-0.56 | ||
| Q3 24 | $0.19 | $-0.34 | ||
| Q2 24 | $0.25 | $-0.40 | ||
| Q1 24 | $0.16 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $5.6M | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $85.8M | $1.1B |
| 总资产 | $105.6M | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资LWAYRXRX
| Q4 25 | $5.6M | $743.3M | ||
| Q3 25 | $23.0M | $659.8M | ||
| Q2 25 | $21.2M | $525.1M | ||
| Q1 25 | $19.4M | $500.5M | ||
| Q4 24 | $16.7M | $594.4M | ||
| Q3 24 | $20.6M | $427.6M | ||
| Q2 24 | $14.6M | $474.3M | ||
| Q1 24 | $12.0M | $296.3M |
总债务LWAYRXRX
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | $2.5M | — |
股东权益LWAYRXRX
| Q4 25 | $85.8M | $1.1B | ||
| Q3 25 | $82.8M | $1.0B | ||
| Q2 25 | $78.7M | $919.1M | ||
| Q1 25 | $74.2M | $933.9M | ||
| Q4 24 | $71.9M | $1.0B | ||
| Q3 24 | $71.5M | $524.6M | ||
| Q2 24 | $68.0M | $584.4M | ||
| Q1 24 | $63.5M | $401.2M |
总资产LWAYRXRX
| Q4 25 | $105.6M | $1.5B | ||
| Q3 25 | $109.5M | $1.4B | ||
| Q2 25 | $98.3M | $1.3B | ||
| Q1 25 | $93.7M | $1.3B | ||
| Q4 24 | $90.5M | $1.4B | ||
| Q3 24 | $91.3M | $726.5M | ||
| Q2 24 | $84.9M | $775.9M | ||
| Q1 24 | $82.8M | $557.8M |
负债/权益比LWAYRXRX
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | 0.04× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $267.0K | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $-17.4M | $-47.3M |
| 自由现金流率自由现金流/营收 | -31.5% | -133.1% |
| 资本支出强度资本支出/营收 | 31.9% | 3.5% |
| 现金转化率经营现金流/净利润 | 0.11× | — |
| 过去12个月自由现金流最近4个季度 | $-16.4M | $-378.3M |
8季度趋势，按日历期对齐
经营现金流LWAYRXRX
| Q4 25 | $267.0K | $-46.1M | ||
| Q3 25 | $6.9M | $-117.4M | ||
| Q2 25 | $3.9M | $-76.4M | ||
| Q1 25 | $-150.0K | $-132.0M | ||
| Q4 24 | $-2.6M | $-115.4M | ||
| Q3 24 | $7.5M | $-59.2M | ||
| Q2 24 | $6.5M | $-82.2M | ||
| Q1 24 | $1.5M | $-102.3M |
自由现金流LWAYRXRX
| Q4 25 | $-17.4M | $-47.3M | ||
| Q3 25 | $1.8M | $-117.6M | ||
| Q2 25 | $1.6M | $-79.6M | ||
| Q1 25 | $-2.4M | $-133.8M | ||
| Q4 24 | $-3.8M | $-116.7M | ||
| Q3 24 | $5.9M | $-63.8M | ||
| Q2 24 | $5.1M | $-83.4M | ||
| Q1 24 | $-923.0K | $-109.0M |
自由现金流率LWAYRXRX
| Q4 25 | -31.5% | -133.1% | ||
| Q3 25 | 3.1% | -2272.5% | ||
| Q2 25 | 3.0% | -413.9% | ||
| Q1 25 | -5.1% | -907.4% | ||
| Q4 24 | -8.2% | -2567.7% | ||
| Q3 24 | 12.8% | -244.6% | ||
| Q2 24 | 10.4% | -578.5% | ||
| Q1 24 | -2.1% | -789.9% |
资本支出强度LWAYRXRX
| Q4 25 | 31.9% | 3.5% | ||
| Q3 25 | 9.0% | 4.7% | ||
| Q2 25 | 4.3% | 16.4% | ||
| Q1 25 | 4.8% | 12.4% | ||
| Q4 24 | 2.7% | 28.6% | ||
| Q3 24 | 3.3% | 17.5% | ||
| Q2 24 | 2.9% | 8.2% | ||
| Q1 24 | 5.5% | 48.2% |
现金转化率LWAYRXRX
| Q4 25 | 0.11× | — | ||
| Q3 25 | 1.96× | — | ||
| Q2 25 | 0.92× | — | ||
| Q1 25 | -0.04× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.50× | — | ||
| Q2 24 | 1.73× | — | ||
| Q1 24 | 0.64× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LWAY
| Drinkable Kefirotherthan Pro Bugs | $47.8M | 86% |
| Cheese | $4.7M | 8% |
| Cream And Other | $1.7M | 3% |
| Other | $1.2M | 2% |
RXRX
暂无分部数据
